Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses-Reference-Cited by-同舟云学术

Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses

Published:2021-01 Issue: Volume:142 Page:1-9
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Schubert Nil A.^ORCID,Schild Linda,van Oirschot Stijn^ORCID,Keller Kaylee M.,Alles Lindy K.,Vernooij Lindy,Nulle Marloes E.,Dolman M. Emmy M.,van den Boogaard Marlinde L.,Molenaar Jan J.

Funder

Dutch Research Council

European Research Council

European Union's Horizon 2020 research and innovation program

Dutch Foundation Children Cancer-free

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference45 articles.

1. Neuroblastoma: biology, prognosis, and treatment;Park;Hematol Oncol Clin N Am,2010

2. Recent advances in neuroblastoma;Maris;N Engl J Med,2010

3. The p53 pathway and its inactivation in neuroblastoma;Tweddle;Canc Lett,2003

4. Prognostic significance of MDM2 gene expression in childhood neuroblastoma;Inomistova;Exp Oncol,2015

5. Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication;Wolf;BMC Canc,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16

2. A novel cuproptosis-related gene signature predicting overall survival in pediatric neuroblastoma patients;Frontiers in Pediatrics;2022-12-07

3. Chromosome 11q loss and MYCN amplification demonstrate synthetic lethality with checkpoint kinase 1 inhibition in neuroblastoma;Frontiers in Oncology;2022-09-27

4. Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup;Scientific Reports;2022-07-20

5. Target actionability review to evaluate CDK4/6 as a therapeutic target in paediatric solid and brain tumours;European Journal of Cancer;2022-07